Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11687211 | 0.87 | TP53 (0.35) | TP53ALDH1A1TSHRTDP1 | |
| SCHEMBL10577521 | 0.82 | TP53 (0.32) | TP53ALDH1A1 | |
| SCHEMBL28860684 | 0.82 | TP53 (0.32) | TP53 | |
| SCHEMBL13987981 | 0.78 | TSHR (0.31) | ALDH1A1TSHR | |
| SCHEMBL3902662 | 0.74 | LMNA (0.36) | TP53ALDH1A1LMNATSHRTDP1 | |
| SCHEMBL2407172 | 0.74 | TP53 (0.50) | TP53ALDH1A1LMNATSHRTDP1 | |
| SCHEMBL13703412 | 0.73 | TP53 (0.35) | TP53ALDH1A1TSHRTDP1 | |
| SCHEMBL1743181 | 0.72 | — | — | |
| SCHEMBL73997 | 0.72 | — | — | |
| SCHEMBL42054 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3921300-A1 | FORMULATIONS OF CANNABIDIOL DERIVATIVES AND THEIR USE AS MODULATORS OF CANNABINOID RECEPTOR TYPE 2 (CB2) | Emerald Health Pharmaceuticals Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2020163612-A1 | FORMULATIONS OF CANNABIDIOL DERIVATIVES AND THEIR USE AS MODULATORS OF CANNABINOID RECEPTOR TYPE 2 (CB2) | EMERALD HEALTH PHARMACEUTICALS INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20080018238-A1 | Use Of Phenothiazine-S-Oxides And Phenothiazine -S,S-Dioxides In The Form Of Matrix Materials For Organic Light-Emitting Diodes | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-24 | — | — | US | disclosed |